Biologics Safety Testing Market to Grow at a CAGR of 12.2% to Reach $4.9 Billion by 2022

About This Presentation
Title:

Biologics Safety Testing Market to Grow at a CAGR of 12.2% to Reach $4.9 Billion by 2022

Description:

Bharat Book Bureau provides the report on “25% Discount on Biologics Safety Testing Market Forecast to 2022 valid upto 31st Aug, 2017”, ()The report provides the positive trend of R&D investment in the life science industry, and an increase in the number of new drug launches are factors driving the growth of this market. – PowerPoint PPT presentation

Number of Views:11

less

Transcript and Presenter's Notes

Title: Biologics Safety Testing Market to Grow at a CAGR of 12.2% to Reach $4.9 Billion by 2022


1
Biologics Safety Testing Market Forecast to 2022
2
Summary
  • The biologics safety testing market was valued at
    USD 2.75 billion in 2017 and expected to grow at
    a CAGR of 12.2 to a USD 4.90 billion market by
    2022.Growth in pharmaceutical and biotechnology
    industry driven by governmentsupport, the
    positive trend of RD investment in the life
    science industry, andan increase in the number
    of new drug launches are factors driving the
    growth of this market. On the other hand, the
    time-consuming approval process fornew drugs is
    considered a restraint for the market.
  • Kits reagents segment is expected to register
    the highest CAGR during the forecast period
  • The biologics safety testing market is classified
    on the basis of product andservice into kits
    reagents, services, and instruments. The kits
    reagentssegment is expected to register highest
    growth rate during the forecast period. This
    growth can be attributed to the reoccurring
    purchase of kits reagents,which is required
    for running tests.

3
(No Transcript)
4
  • Endotoxin tests segment is accounted for largest
    share in the market
  • The biologics safety testing market is classified
    by test type into endotoxin tests, sterility
    tests, cell line authentification and
    characterization tests, residual host
    contamination detection tests, adventitious agent
    detection tests, bioburdentests, and other
    tests. The endotoxin tests segment is expected to
    register thehighest growth rate during the
    forecast period. This growth can be attributed to
    the increase in the number of drug launches.
  • Increase initiative for immunization, increase
    company investment in vaccines development drives
    growth of the vaccines and therapeutics
    developmentsegment
  • By application, the biologics safety testing
    market is segmented into vaccine therapeutics
    development blood and blood-related products
    testing cellularand gene therapy tissue and
    tissue-related products testing and stem
    cellresearch.

5
  • The vaccine and therapeutics development segment
    are expected to registerhighest CAGR during the
    forecast period. The growth in this segment
    primarily attributed to initiatives for
    immunization and increased company investment in
    the development of vaccines.
  • North America is account for the largest regional
    segment in the market
  • Geographically, the biologics safety testing
    market is dominated by NorthAmerica, followed by
    Europe. The North American region is estimated
    toaccount for the largest share of the market in
    2017 and the trend is expected to continue during
    the forecast period.
  • The primary interviews conducted for this report
    can be categorized as follows
  • By Company Type - Tier 1 43, Tier 2 14 and
    Tier 3 43
  • By Designation C level 14, Director level
    43, Others 43
  • By Region North America - 29, Europe 14,
    APAC 43, RoW 14

6
  • Key players operating in the biologics safety
    testing market include
  • Lonza Group LTD. (Switzerland)
  • Charles River Laboratories (U.S.)
  • Merck KGaA (Germany), SGS SA (Switzerland)
  • WuXi Apptec (China)
  • Thermo Fisher Scientific Inc. (U.S.)
  • Sartorius AG (Germany)
  • Cytovance Biologics, Inc. (U.S.)
  • Pace Analytical Services Inc. (U.S.)
  • Toxikon Corporation (U.S.).

7
Study Coverage
  • The report analyses the biologics safety testing
    market by product service, test type,
    applications, and regions.
  • Apart from comprehensive geographic and product
    service analysis andmarket sizing, the report
    also provides the competitive landscape that
    covers the growth strategies adopted by industry
    players over the last three years.
  • In addition, the report profiles companies with
    developments, and strategies adopted by key
    players to maintain and increase their shares in
    the market.
  • The market research data, market size, and
    forecast of the future trends will help key
    market players and new entrants to make the
    necessary decisionsto be successful in the
    market.

8
Related Reports
  • Top 10 Bioprocess Technology Market by Cell
    Culture, Cell Expansion, CellCounting, Cell Line
    Development, Flow Cytometry, Single-Use
    Bioprocessing, Biologics Safety Testing,
    Tangential Flow Filtration, Virus Filtration
    Region - Forecast to 2021
  • 2016 Global Biological Safety Testing Market
    Status, 2011-2022 MarketHistorical and
    Forecasts, Professional Market Research Report
  • Food Safety Testing Market (by Contaminants,
    Pathogens, Type of FoodTested, Technology/Method
    and Regional Analysis) - Global Forecast to 2021
  • United States Biological Safety Testing Market
    Report 2016
  • Food Safety Testing (By Contaminant, Pathogen,
    Technology Region) -Global Forecast

9
Full Reports
Biologics Safety Testing Market Forecast to 2022
Contact us atBharat Book Bureau Tel 91 22
27810772 / 27810773 Email poonam_at_bharatbook.com O
ur Blog https//www.bharatbook.com/blog/ Twitter
https//twitter.com/researchbook Facebook
https//www.facebook.com/BharatBook3B LinkedIn
http//www.linkedin.com/company/bharat-book-bureau
Write a Comment
User Comments (0)